Article Text

Download PDFPDF

Immunohistochemical analysis of amylase isoenzymes in thyroid cancer.
  1. M Higashiyama,
  2. S Doi,
  3. N Tomita,
  4. T Monden,
  5. M Murotani,
  6. Y Kawasaki,
  7. T Kobayashi,
  8. T Shimano,
  9. M Ogawa,
  10. S Takai
  1. Second Department of Surgery, Osaka University School of Medicine, Japan.


    The expression of amylase in various histological types of thyroid cancer was studied by an immunohistochemical technique, using a polyclonal antiamylase antiserum and two monoclonal antibodies specific for salivary and pancreatic-type amylases, respectively. Amylase was expressed in 21 of 24 (88%) thyroid cancers by polyclonal antiserum analysis. Analysis by monoclonal antibodies, however, showed that only 13 (54%) cases and three (13%) cases contained salivary-type and pancreatic-type amylases, respectively. Moreover, immunoreactivity for pancreatic-type amylase was detected only in medullary carcinoma; other histological types were positive for salivary-type amylase. These results show that thyroid cancer frequently expresses amylase, and suggest that the differences between amylase isoenzymes in thyroid cancer may correlate with those found between cellular origin of tumour.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.